Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5LL7

Crystal structure of KPC-2 carbapenemase in complex with a phenyl boronic inhibitor.

5LL7 の概要
エントリーDOI10.2210/pdb5ll7/pdb
関連するPDBエントリー5MGI
分子名称Beta-lactamase, (~{E})-3-[2-(dihydroxyboranyl)phenyl]prop-2-enoic acid, 1,2-ETHANEDIOL, ... (4 entities in total)
機能のキーワードcarbapenemase, beta-lactamase, phenyl boronic inhibitor, hydrolase
由来する生物種Escherichia coli
タンパク質・核酸の鎖数1
化学式量合計28769.10
構造登録者
Vicario, M.,Celenza, G.,Bellio, P.,Perilli, M.G.,Tondi, D.,Cendron, L. (登録日: 2016-07-26, 公開日: 2018-02-21, 最終更新日: 2024-10-16)
主引用文献Celenza, G.,Vicario, M.,Bellio, P.,Linciano, P.,Perilli, M.,Oliver, A.,Blazquez, J.,Cendron, L.,Tondi, D.
Phenylboronic Acid Derivatives as Validated Leads Active in Clinical Strains Overexpressing KPC-2: A Step against Bacterial Resistance.
Chemmedchem, 13:713-724, 2018
Cited by
PubMed Abstract: The emergence and dissemination of multidrug resistant (MDR) pathogens resistant to nearly all available antibiotics poses a significant threat in clinical therapy. Among them, Klebsiella pneumoniae clinical isolates overexpressing KPC-2 carbapenemase are the most worrisome, extending bacterial resistance to last-resort carbapenems. In this study, we investigate the molecular recognition requirements in the KPC-2 active site by small phenylboronic acid derivatives. Four new phenylboronic acid derivatives were designed and tested against KPC-2. For the most active, despite their simple chemical structures, nanomolar affinity was achieved. The new derivatives restored susceptibility to meropenem in clinical strains overexpressing KPC-2. Moreover, no cytotoxicity was detected in cell-viability assays, which further validated the designed leads. Two crystallographic binary complexes of the best inhibitors binding KPC-2 were obtained at high resolution. Kinetic descriptions of slow binding, time-dependent inhibition, and interaction geometries in KPC-2 were fully investigated. This study will ultimately lead toward the optimization and development of more-effective KPC-2 inhibitors.
PubMed: 29356380
DOI: 10.1002/cmdc.201700788
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.4 Å)
構造検証レポート
Validation report summary of 5ll7
検証レポート(詳細版)ダウンロードをダウンロード

236371

件を2025-05-21に公開中

PDB statisticsPDBj update infoContact PDBjnumon